What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Gene
His primary scientific interests are in Neurology, Internal medicine, Dementia, Pathology and Alzheimer's disease.
His Neurology study combines topics from a wide range of disciplines, such as Area under the curve, Cerebrospinal fluid, Differential diagnosis, Neuroimaging and Disease.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
Oskar Hansson has researched Dementia in several fields, including Biomarker and Amyloid beta.
His work deals with themes such as Context and Magnetic resonance imaging, which intersect with Pathology.
His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Central nervous system disease, Degenerative disease, Cognition, Positron emission tomography and Cognitive disorder.
His most cited work include:
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study (1386 citations)
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study (1386 citations)
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Disease, Neurology, Pathology and Dementia.
His Internal medicine research includes elements of Endocrinology and Oncology.
The various areas that Oskar Hansson examines in his Disease study include Cognition, Neuroimaging and Neuroscience.
His Neurology research includes themes of Gastroenterology, Atrophy, Parkinson's disease, Apolipoprotein E and Cohort.
His research on Pathology frequently links to adjacent areas such as Positron emission tomography.
Many of his studies on Dementia apply to Cognitive impairment as well.
He most often published in these fields:
- Internal medicine (39.04%)
- Disease (33.60%)
- Neurology (33.60%)
What were the highlights of his more recent work (between 2019-2021)?
- Disease (33.60%)
- Internal medicine (39.04%)
- Dementia (30.56%)
In recent papers he was focusing on the following fields of study:
Oskar Hansson spends much of his time researching Disease, Internal medicine, Dementia, Neurology and Biomarker.
His Disease study is concerned with the field of Pathology as a whole.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology.
Oskar Hansson has included themes like Cognitive impairment, Magnetic resonance imaging, Alzheimer's disease, Positron emission tomography and Cohort in his Dementia study.
His research in Neurology intersects with topics in Standardized uptake value, Pathological, Gastroenterology, Neuropathology and Vascular dementia.
His studies in Biomarker integrate themes in fields like Context and Clinical validity.
Between 2019 and 2021, his most popular works were:
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (115 citations)
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders (105 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Oskar Hansson focuses on Disease, Neurology, Internal medicine, Biomarker and Dementia.
His study in Neurology is interdisciplinary in nature, drawing from both Apolipoprotein E, Pathological and Cognition.
His Internal medicine study combines topics from a wide range of disciplines, such as Magnetic resonance imaging, Oncology and Cardiology.
Oskar Hansson has included themes like Differential diagnosis, Cerebrospinal fluid, Pathology, Frontotemporal dementia and Intensive care medicine in his Biomarker study.
His Pathology research integrates issues from Immunoprecipitation and Acute-phase protein.
Oskar Hansson combines subjects such as Alzheimer's disease, Neuropathology, Area under the curve and Cohort with his study of Dementia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
